# LEVOTHYROXINE SODIUM
> **ANDA217495** · Abbreviated New Drug Application (Generic) · Sponsor: XIROMED · Approved 2024-11-29
## Drug
- **FDA Application Number:** ANDA217495
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LEVOTHYROXINE SODIUM
- **Generic name:** Levothyroxine Sodium
- **Active ingredients:** LEVOTHYROXINE SODIUM
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** XIROMED
- **First approval:** 2024-11-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217495)
---
*MORVS · CC0 1.0*